MoneyWorks4Me

SMS Lifesciences - Quaterly Results

09 Aug 2024 Evaluate
The June 2024 quarter revenue stood at Rs. 865.71 millions, up 16.11% as compared to Rs. 745.60 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 821.54% to Rs. 64.60  millions from Rs. 7.01 millions in the previous quarter.Operating profit surged to 141.96 millions from the corresponding previous quarter of 57.07 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 865.71 745.60 16.11 865.71 745.60 16.11 3000.02 3152.42 -4.83
Other Income 4.30 5.83 -26.24 4.30 5.83 -26.24 38.37 28.82 33.14
PBIDT 141.96 57.07 148.75 141.96 57.07 148.75 382.68 292.88 30.66
Interest 21.59 18.20 18.63 21.59 18.20 18.63 89.02 50.94 74.75
PBDT 120.37 38.87 209.67 120.37 38.87 209.67 293.66 265.46 10.62
Depreciation 25.00 25.28 -1.11 25.00 25.28 -1.11 102.54 81.73 25.46
PBT 95.37 13.59 601.77 95.37 13.59 601.77 191.12 183.73 4.02
TAX 30.77 6.58 367.63 30.77 6.58 367.63 60.47 51.55 17.30
Deferred Tax 0.77 2.58 -70.16 0.77 2.58 -70.16 19.94 20.05 -0.55
PAT 64.60 7.01 821.54 64.60 7.01 821.54 130.65 132.18 -1.16
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 16.40 7.65 114.24 16.40 7.65 114.24 12.76 9.29 37.30
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..